- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/54 - Sulfur atoms
Patent holdings for IPC class C07D 211/54
Total number of patents in this class: 136
10-year publication summary
|
14
|
8
|
12
|
11
|
12
|
11
|
16
|
15
|
6
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4431 |
9 |
| Hoffmann-La Roche Inc. | 3804 |
8 |
| F. Hoffmann-La Roche AG | 7816 |
7 |
| Cephalon LLC | 121 |
6 |
| Inflazome Limited | 84 |
5 |
| Canopy Growth Corporation | 212 |
4 |
| Enanta Pharmaceuticals, Inc. | 421 |
4 |
| Bristol-myers Squibb Company | 4747 |
3 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 319 |
3 |
| Samsung Display Co., Ltd. | 38721 |
2 |
| The Regents of the University of California | 20790 |
2 |
| Genentech, Inc. | 4113 |
2 |
| Boehringer Ingelheim International GmbH | 4487 |
2 |
| Merck Patent GmbH | 5731 |
2 |
| Syngenta Crop Protection AG | 6707 |
2 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 308 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
2 |
| Idemitsu Kosan Co., Ltd. | 4253 |
2 |
| Northeastern University | 1295 |
2 |
| Orion Corporation | 774 |
2 |
| Other owners | 65 |